COVID-19, Vaccines, and Retinal Vascular Disease
-
By
-
Nirojini Sivachandran, MD, PhD, FRCSC
-
May 14, 2026
-
2 min
By
Nirojini Sivachandran, MD, PhD, FRCSC
May 14, 2026
by Nirojini Sivachandran, MD, PhD, FRCSC
May 14, 2026
Among patients who proceeded to surgery after preoperative testing, 96.9% successfully adapted to laser blended vision.
September 11, 2026
A phoropter-based test predicted successful adaptation to laser blended vision in 96.9% of treated patients
September 13, 2026
Researchers evaluated how IOL materials held up after approximately 6 months outside the International Space Station.
September 11, 2026